StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report report published on Friday. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
NASDAQ BLPH opened at $0.04 on Friday. Bellerophon Therapeutics has a 1 year low of $0.03 and a 1 year high of $0.46. The company has a market cap of $428,050.00, a PE ratio of -0.04 and a beta of 0.70. The stock’s 50-day moving average price is $0.04 and its two-hundred day moving average price is $0.05.
About Bellerophon Therapeutics
Read More
- Five stocks we like better than Bellerophon Therapeutics
- How to Find Undervalued Stocks
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Retail Stocks Investing, Explained
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.